U.S. drugmaker Orexigen files for Chapter 11 bankruptcy

March 12 (Reuters) - Drugmaker Orexigen Therapeutics Inc said on Monday it filed for Chapter 11 bankruptcy protection and will also file a motion to pursue an auction and sale process of substantially all its assets.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.